Andrographolide Sulfonate Is a Promising Treatment to Combat Methicillin-resistant Staphylococcus aureus and Its

Lulu Zhang1,2, Bo Wen1, Mei Bao1,2

  • 1Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.

Insights

Andrographolide sulfonate (AS) effectively inhibits Methicillin-resistant Staphylococcus aureus (MRSA) biofilms by downregulating key genes and metabolites. This natural compound offers a promising strategy for combating drug-resistant bacterial infections.

Area of Science:

  • Microbiology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat due to its drug resistance, often exacerbated by biofilm formation.
  • Biofilms contribute to MRSA's pathogenicity and resistance, necessitating strategies for their inhibition and elimination.
  • Andrographolide sulfonate (AS), derived from the traditional herb Andrographis paniculata, is explored for its therapeutic potential.

Purpose of the Study:

  • To investigate the inhibitory effects of Andrographolide sulfonate (AS) on MRSA and its biofilms.
  • To elucidate the underlying molecular mechanisms by which AS affects MRSA biofilm formation and gene expression.

Main Methods:

  • In vitro antibacterial assays and morphological observations were employed to assess AS efficacy against MRSA biofilms.
  • Real-time PCR was utilized to analyze the expression of critical biofilm-related genes.
  • Metabonomic profiling was conducted to identify changes in endogenous metabolites influenced by AS treatment.

Main Results:

  • AS demonstrated significant antibacterial activity against MRSA, with a minimum inhibitory concentration of 50 μg/ml.
  • AS effectively inhibited MRSA biofilm formation and enhanced biofilm permeability.
  • AS treatment led to the downregulation of genes involved in quorum sensing (agrD, sarA), adhesion (clfA, fnbB), intercellular adhesion (icaA, icaD, PIA), and eDNA release (cidA).
  • Five key biofilm-related metabolites, including anthranilic acid and D-lactic acid, were downregulated by AS.

Conclusions:

  • Andrographolide sulfonate exhibits potent anti-MRSA and anti-biofilm activity.
  • The mechanisms involve the modulation of crucial gene expression and metabolic pathways related to biofilm formation.
  • AS represents a promising natural compound for developing novel therapeutic strategies against MRSA infections.